EMEA-001060-PIP01-10
Key facts
| Active substance |
(E)-4-(2-(6-(2-(2-(2-[18F]fluoroethoxy)ethoxy)ethoxy)pyridin-3-yl)vinyl)-N-methylbenzenamine
|
| Therapeutic area |
Diagnostic
|
| Decision number |
P/46/2011
|
| PIP number |
EMEA-001060-PIP01-10
|
| Pharmaceutical form(s) |
Solution for injection
|
| Condition(s) / indication(s) |
Diagnosis of Alzheimer's disease
|
| Route(s) of administration |
Intravenous use
|
| Contact for public enquiries |
Eli Lilly and Company Limited
E-mail: eu_paediatric@lilly.com |
| Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|